TLR9 and endometrial cancer: In the study by Ashton et al. [14], haplotype analysis showed that the combination of the variant alleles of the two TLR9 polymorphisms, rs5743836 and rs187084, were protective in endometrial cancer (OR 0.11, 95% CI 0.03-0.44).